Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

The HTA has funded the PART Trial - A randomised controlled trial of Partial prostate Ablation versus Radical prosTatectomy (PART) in intermediate risk, unilateral clinically localised prostate cancer. Work on the trial officially started on 1st January 2015, further information on the trial and its progress will be available soon on the OCTRU Current Projects Page.

PART Trial Logo

Similar stories

SITU announces a trio of new trials

SITU has announced the launch of three major new clinical trials. Funded by the NIHR, these studies are providing evidence for the treatment of chronic low back pain, knee osteoarthritis, and ACL injuries.